Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 9/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29947757 | 0.82 | SIGMAR1 (0.47) | SIGMAR1MEN1KMT2ADHFRKDM1A | |
| SCHEMBL12424682 | 0.81 | MTNR1A (0.41) | KDM1AALDH1A1GAARAB9A | |
| SCHEMBL12424703 | 0.80 | MTNR1A (0.40) | MEN1KMT2AKDM1AALDH1A1KDM4E | |
| SCHEMBL1414206 | 0.75 | SIGMAR1 (0.57) | SIGMAR1DHFRALDH1A1 | |
| SCHEMBL12048739 | 0.74 | SIGMAR1 (0.50) | SIGMAR1DHFRMCL1ALDH1A1MAPT | |
| SCHEMBL12048742 | 0.74 | DHFR (0.45) | SIGMAR1MEN1KMT2ADHFRRAB9A | |
| SCHEMBL14465459 | 0.73 | SIGMAR1 (0.49) | SIGMAR1DHFRMCL1 | |
| SCHEMBL12048709 | 0.73 | SIGMAR1 (0.49) | SIGMAR1DHFRMCL1SLC6A2SLC6A4 | |
| SCHEMBL12258277 | 0.72 | DHFR (0.49) | SIGMAR1DHFRMCL1ALDH1A1KDM4E | |
| SCHEMBL1683320 | 0.71 | SIGMAR1 (0.63) | SIGMAR1DHFRMCL1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9028977-B2 | Compound, method for preparing same and organic electronic device using same | LG CHEM, LTD. (KR) | 2015-05-12 | — | — | US | disclosed |
| US-20110168992-A1 | NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME | LG CHEM, LTD. (KR) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110168992-A1 | NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME | OR10J3, USE1, NOTUM | SIGMAR1 2924/4885MEN1 1276/4885KMT2A 1814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.